Our services

Advance your compounds to the clinic with confidence

We are seasoned specialists in chronic pain and neurodegenerative disease drug discovery with a deep understanding for Client needs. We have a proven track record of developing customer specific solutions for our Clients to ensure project progress.
Read more arrow_forward

We deliver high quality information

We’re not just providing data, we provide valuable information and clear answers to complex biological questions.

We accelerate your decision-making

Thanks to our highly experienced team, proprietary discovery platform and streamlined operations, we can shorten your project lead times.

Fast access to ground-breaking assays

We develop highly innovative in vitro assays based on complex biology that provide translationally relevant information.


An approach you can trust

We provide fully collaborative support, tailored to each individual study. Our Clients value our interactive and open communication style, our high capacity, quality and delivery precision needed for projects from target discovery and screening to lead optimization.

Read more

Our platform

Our unique discovery platform

Our team of highly experienced neurobiologists, stem cell researchers and engineers, has developed a unique and patent protected discovery platform which enables development of innovative in vitro assays of enhanced translational value.
Read more arrow_forward

News and events

Latest news and insights

Cellectricon values scientific exchange and we invite you to take part of our latest news, newsletters and to learn about upcoming events.

Read more

April 2-5, 2020
AAT-AD/PD Focus Meeting 2020
The AAT-AD/PD Focus Meeting 2020 will be a held as a virtual meeting. The meeting will, for a second year,...
April 9, 2020. 5 PM CEST / 11 AM EDT / 8 AM PDT
Webinar - Fibrillar and oligomeric constructs of neurodegenerative disease associated peptides and their utility in disease modelling
Webinar Description: Spreading of neurodegenerative disease associated peptides (NDAPs; e.g. tau and alpha-synuclein) within the human brain is one of...
March 11, 2020
8th Annual Neuroscience Virtual Conference
The 8th Annual Neuroscience Virtual Conference will be broadcasted live on March 11, 2020. This event will once again bring...
Cellectricon and StressMarq Biosciences collaborate to develop next generation reagents and assays to advance neurodegenerative disease research
Mölndal, Sweden and Victoria, BC, Canada Cellectricon, a collaborative services provider dedicated to advancing drug discovery and research in the...
February 25-27, 2020
Neurodegenerative Drug Development Summit
The 8th Annual Neurodegenerative Drug Development Summit takes place in Boston, MA on February 25-27. The meeting is dedicated to...
Towards “disease in a dish” microfluidic models for studying the interaction of bone and neuronal cells
In August, Cellectricon welcomed our new coworker Lydia Moll. Lydia will carry out her PhD project at the company over...
Cellectricon to collaborate with world-renowned pain scientists in the EU-funded Bone Pain Network
Cellectricon, a collaborative services provider dedicated to advance drug discovery and research in the areas of chronic pain and neurodegenerative...
Cellectricon announces new opportunity for the discovery of highly differentiated therapeutics for neurodegenerative diseases
Launch of novel, high throughput in vitro platform will help researchers find molecules that can prevent prion-like spreading of neurodegenerative...

Get the latest news & events – sign up for our newsletter

Read about our Privacy Policy